Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Successful use of bivalirudin in place of heparin infusion for pulmonary vein isolation using a cryoballoon catheter in a patient with heparin allergy.

Ellis ER.

HeartRhythm Case Rep. 2017 Jan 3;3(1):10-12. doi: 10.1016/j.hrcr.2016.10.004. eCollection 2017 Jan. No abstract available.

2.

The Rise and Fall of Anticoagulation with Bivalirudin During Percutaneous Coronary Interventions: A Review Article.

Andreou C, Maniotis C, Koutouzis M.

Cardiol Ther. 2017 Jun;6(1):1-12. doi: 10.1007/s40119-017-0082-x. Epub 2017 Jan 19. Review.

3.
4.

Second-generation drug-eluting stents in the elderly patients with acute coronary syndrome: the in-hospital and 12-month follow-up of the all-comer registry.

Wańha W, Kawecki D, Roleder T, Morawiec B, Gładysz S, Kowalówka A, Jadczyk T, Adamus B, Pawłowski T, Smolka G, Kaźmierski M, Ochała A, Nowalany-Kozielska E, Wojakowski W.

Aging Clin Exp Res. 2016 Nov 10. [Epub ahead of print]

5.
6.

Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.

Galasso G, Mirra M, De Luca G, Piscione F.

Transl Med UniSa. 2016 May 16;14:54-63. eCollection 2016 May.

7.

Thrombolysis Followed by Early Percutaneous Coronary Intervention via Transradial Artery Approach in Patients with ST-Segment Elevation Infarction.

Wang YB, Fu XH, Gu XS, Geng W, Zhao YJ, Hao GZ, Jiang YF, Li SQ, Fan WZ.

Acta Cardiol Sin. 2014 Jul;30(4):284-91.

8.

Bivalirudin Anticoagulant Therapy With or Without Platelet Glycoprotein IIb/IIIa Inhibitors During Transcatheter Coronary Interventional Procedures: A Meta-Analysis.

Li J, Yu S, Qian D, He Y, Jin J.

Medicine (Baltimore). 2015 Aug;94(32):e1067. doi: 10.1097/MD.0000000000001067. Review.

9.

Incorporating linked healthcare claims to improve confounding control in a study of in-hospital medication use.

Franklin JM, Eddings W, Schneeweiss S, Rassen JA.

Drug Saf. 2015 Jun;38(6):589-600. doi: 10.1007/s40264-015-0292-x.

10.

Bleeding risk stratification in an era of aggressive management of acute coronary syndromes.

Abu-Assi E, Raposeiras-Roubín S, García-Acuña JM, González-Juanatey JR.

World J Cardiol. 2014 Nov 26;6(11):1140-8. doi: 10.4330/wjc.v6.i11.1140. Review.

11.

Interaction between access choice and pharmacotherapy for coronary intervention: the results of a UK survey.

Kinnaird TD, Ossei-Gerning N, Mitra R, Anderson RA.

Open Heart. 2014 Jun 13;1(1):e000094. doi: 10.1136/openhrt-2014-000094. eCollection 2014.

12.

Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis.

Kwok CS, Rao SV, Myint PK, Keavney B, Nolan J, Ludman PF, de Belder MA, Loke YK, Mamas MA.

Open Heart. 2014 Feb 13;1(1):e000021. doi: 10.1136/openhrt-2013-000021. eCollection 2014.

13.

Targeting platelet thrombin receptor signaling to prevent thrombosis.

Wallace EL, Smyth SS.

Pharmaceuticals (Basel). 2013 Aug 2;6(8):915-28. doi: 10.3390/ph6080915.

14.

Safety and efficacy of bivalirudin with glycoprotein IIb/IIIa for high-risk percutaneous coronary intervention.

Deshpande NV, Pratiti R, Admane P, Mukherjee D, Mardikar HM.

Indian Heart J. 2012 Sep-Oct;64(5):444-8. doi: 10.1016/j.ihj.2012.07.022. Epub 2012 Jul 27.

15.

Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation.

Holinstat M, Colowick NE, Hudson WJ, Blakemore D, Chen Q, Hamm HE, Cleator JH.

J Thromb Thrombolysis. 2013 Feb;35(2):209-22. doi: 10.1007/s11239-012-0812-9.

16.

Percutaneous coronary intervention in elderly patients: is it beneficial?

Shanmugasundaram M.

Tex Heart Inst J. 2011;38(4):398-403. Review.

17.

Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics.

Brown C, Joshi B, Faraday N, Shah A, Yuh D, Rade JJ, Hogue CW.

Anesth Analg. 2011 Apr;112(4):777-99. doi: 10.1213/ANE.0b013e31820e7e4f. Epub 2011 Mar 8. Review.

18.

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW.

Eur Heart J. 2011 Jan;32(2):205-17. doi: 10.1093/eurheartj/ehq406. Epub 2011 Jan 6.

19.

Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention.

Vidi VD, Matheny ME, Agarwal V, Arora N, Donnelly S, Bangalore S, Resnic FS.

Am J Cardiol. 2010 Nov 1;106(9):1234-40. doi: 10.1016/j.amjcard.2010.06.047. Epub 2010 Sep 9.

Supplemental Content

Support Center